Gene-edited cells that evade rejection show promise in type 1 diabetes

May Be Interested In:Stunning artworks give this ‘boho wild’ 19th-century apartment in Helsingborg its distinct charm


A transmission electron micrograph of a section through pancreas tissue, showing cells that produce insulin

STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY/Alamy

The first human trial of insulin-producing cells that have been gene-edited to evade immune attack is a success so far. The cells have survived and produced insulin for a month after being injected into a 42-year-old man with type 1 diabetes early in December.

As a precaution, only a small number of insulin-producing beta cells were injected into a forearm muscle in this initial test, so the man still needs insulin injections. It also remains to be seen how long the…

share Share facebook pinterest whatsapp x print

Similar Content

How to watch Phoenix Suns vs. Los Angeles Clippers: Live stream, TV channel, start time for Monday's NBA game
How to watch Phoenix Suns vs. Los Angeles Clippers: Live stream, TV channel, start time for Monday’s NBA game
Bronze Age butchery and cannibalism unearthed in England
Bronze Age butchery and cannibalism unearthed in England
Blue Cross Blue Shield lawsuit settlement checks will be disbursed soon. Who gets one?
Blue Cross Blue Shield lawsuit settlement checks will be disbursed soon. Who gets one?
England batter Jacob Bethell before an ODI
England in India: Injured Jacob Bethell a doubt for Champions Trophy and Tom Banton called up
Housebuilding, skills, health: UK policies to watch in 2025
Housebuilding, skills, health: UK policies to watch in 2025
Bitcoin Scalability: Addressing the Challenges of Mass
XRP Soars 12% as SEC Acknowledges Grayscale ETF Filing for Review
Daily Dispatch: The Headlines You Can’t Ignore | © 2025 | Daily News